A-Z of Clinical Trials, Research Studies & Medical Evidence Terms

​

Adverse Event (AE)

An Adverse Event (AE) is any unwanted medical occurrence experienced by a patient during a clinical trial or research study. Adverse events may or may not be directly related to the treatment being investigated. Monitoring adverse events helps researchers evaluate treatment safety and identify potential risks associated with new therapies.

 

Blinded Study

A blinded study is a clinical trial design in which participants, researchers, or both do not know which treatment a participant is receiving. Blinding helps reduce bias and improves the reliability of study results. While more common in drug development research, blinded designs are sometimes used in oncology studies when appropriate.

 

Case Report

A case report is a detailed description of an individual patient's medical condition, treatment, and outcome. Case reports can provide valuable insights into rare diseases, unusual presentations, treatment responses, and emerging medical observations. They often contribute to future research and scientific understanding.

 

Case Series

A case series is a collection of case reports involving multiple patients with similar conditions or treatment experiences. Case series help researchers identify patterns, generate research questions, and improve understanding of rare diseases such as Wilms tumor.

 

Clinical Endpoint

A clinical endpoint is a measurable outcome used to determine whether a treatment is effective. Examples include overall survival, event-free survival, relapse rates, tumor response, quality of life, and treatment-related toxicity. Clinical endpoints are fundamental to evaluating new therapies.

 

Clinical Protocol

A clinical protocol is the detailed plan that governs how a clinical trial or research study is conducted. Protocols outline eligibility criteria, treatment schedules, study objectives, safety monitoring procedures, and outcome measures. Adherence to protocols helps ensure scientific integrity and patient safety.

 

Clinical Research Coordinator

A Clinical Research Coordinator is a healthcare professional responsible for managing the day-to-day operations of clinical trials. Responsibilities may include patient enrollment, data collection, regulatory compliance, scheduling assessments, and supporting communication between patients and research teams.

 

Clinical Study

A clinical study is a research project involving human participants designed to answer specific medical questions. Clinical studies may investigate disease causes, treatments, outcomes, quality of life, genetics, survivorship, or healthcare delivery. Clinical studies contribute significantly to advances in Wilms tumor care.

 

Clinical Trial

A clinical trial is a carefully designed research study that evaluates new treatments, medications, procedures, diagnostic tools, or healthcare interventions. Clinical trials play a critical role in improving outcomes for children with Wilms tumor by helping researchers identify safer and more effective treatment approaches.

 

Cohort Study

A cohort study is a research design that follows a group of individuals over time to evaluate health outcomes, risk factors, or treatment effects. Cohort studies provide valuable information about survivorship, late effects, disease patterns, and long-term treatment outcomes.

 

Control Group

A control group is a comparison group used in research studies to help evaluate the effectiveness of an intervention. By comparing outcomes between groups, researchers can determine whether a treatment provides meaningful benefits beyond standard care or natural disease progression.

 

Data Monitoring Committee (DMC)

A Data Monitoring Committee (DMC) is an independent group of experts responsible for reviewing safety and effectiveness data during a clinical trial. The committee helps ensure participant safety and may recommend continuing, modifying, or stopping a study based on emerging results.

 

Double-Blind Study

A double-blind study is a research design in which neither participants nor investigators know which treatment has been assigned. This approach minimizes bias and strengthens the reliability of study findings. Double-blind studies are considered a gold standard in clinical research.

 

Evidence-Based Medicine

Evidence-Based Medicine (EBM) is the practice of making healthcare decisions using the best available scientific evidence combined with clinical expertise and patient preferences. Evidence-based medicine forms the foundation of modern Wilms tumor treatment and survivorship care.

 

Informed Consent

Informed consent is the process through which patients or parents receive detailed information about a clinical trial before agreeing to participate. Information typically includes potential risks, benefits, alternatives, procedures, and participant rights. Informed consent is a fundamental ethical requirement in clinical research.

 

Institutional Review Board (IRB)

An Institutional Review Board (IRB) is an independent committee responsible for reviewing and approving research studies involving human participants. IRBs help protect participant safety, rights, and welfare by ensuring studies meet ethical and regulatory standards.

 

Meta-Analysis

A meta-analysis is a research method that combines data from multiple studies to produce a more comprehensive understanding of a topic. Meta-analyses are highly valued because they can provide stronger evidence than individual studies alone.

 

Multicenter Trial

A multicenter trial is a clinical study conducted at multiple hospitals or research institutions. Multicenter trials allow researchers to enroll larger numbers of participants, improve study diversity, and increase the reliability of results. Many major Wilms tumor studies are international multicenter collaborations.

 

Observational Study

An observational study examines patients and outcomes without assigning a specific intervention. Researchers collect information about real-world experiences, treatments, and outcomes to improve understanding of disease patterns and healthcare practices.

 

Outcome Measure

An outcome measure is a specific result used to evaluate the effectiveness of a treatment or intervention. Outcome measures may include survival rates, quality of life, treatment response, complication rates, and patient-reported outcomes.

 

Patient-Reported Outcome (PRO)

A Patient-Reported Outcome (PRO) is information provided directly by patients regarding symptoms, quality of life, emotional well-being, or treatment experiences. PROs help researchers better understand the patient perspective and evaluate the broader impact of healthcare interventions.

 

Peer Review

Peer review is the process through which scientific research is evaluated by independent experts before publication. Peer review helps ensure research quality, accuracy, validity, and scientific integrity. Most reputable medical journals use peer-review processes.

 

Phase I Clinical Trial

A Phase I Clinical Trial is the first stage of testing a new treatment in humans. The primary objective is to evaluate safety, determine appropriate dosing, and identify potential side effects. Phase I studies typically involve a small number of participants.

 

Phase II Clinical Trial

A Phase II Clinical Trial evaluates whether a treatment shows evidence of effectiveness while continuing to assess safety. These studies usually involve larger numbers of participants than Phase I trials and help determine whether further investigation is warranted.

 

Phase III Clinical Trial

A Phase III Clinical Trial compares a new treatment against the current standard of care. These large studies provide critical information regarding effectiveness, safety, and clinical benefit. Successful Phase III trials often lead to changes in treatment guidelines and clinical practice.

 

Principal Investigator (PI)

A Principal Investigator (PI) is the lead researcher responsible for overseeing a clinical trial or research study. The PI ensures that the study is conducted according to scientific, ethical, and regulatory requirements.

 

Prospective Study

A prospective study follows participants forward in time to observe outcomes as they occur. Prospective research designs are commonly used in clinical trials, survivorship studies, and epidemiological investigations.

 

Randomized Controlled Trial (RCT)

A Randomized Controlled Trial (RCT) is a research study in which participants are randomly assigned to different treatment groups. RCTs are considered one of the highest standards of medical evidence because randomization helps reduce bias and improve reliability.

 

Research Ethics

Research ethics refers to the principles and standards that govern the conduct of scientific studies involving human participants. Ethical research prioritizes participant safety, informed consent, privacy, transparency, and scientific integrity.

 

Retrospective Study

A retrospective study examines existing medical records and historical data to identify patterns, outcomes, and associations. Retrospective studies often provide valuable insights into rare diseases such as Wilms tumor.

 

Standard of Care

The standard of care is the treatment approach widely accepted by medical experts as the most appropriate based on current evidence. Clinical trials often compare new interventions against the existing standard of care to determine whether improvements can be achieved.

 

Statistical Significance

Statistical significance is a mathematical measure used to determine whether research findings are likely due to a true effect rather than chance. Statistical significance helps researchers interpret study results and assess the reliability of conclusions.

 

Systematic Review

A systematic review is a comprehensive analysis of all available research on a specific topic using predefined scientific methods. Systematic reviews help summarize evidence, identify knowledge gaps, and guide healthcare decision-making.

 

Translational Research Study

A translational research study seeks to convert laboratory discoveries into practical clinical applications. These studies help bridge the gap between scientific research and patient care, accelerating the development of improved treatments and diagnostic tools.

 

Trial Enrollment

Trial enrollment is the process through which eligible patients join a clinical research study. Enrollment criteria are carefully defined to ensure participant safety and study validity. Clinical trial participation has played a major role in improving Wilms tumor outcomes over the past several decades.

 

Wilms Tumor Clinical Trial

A Wilms Tumor Clinical Trial is a research study specifically focused on improving the diagnosis, treatment, survivorship care, quality of life, or outcomes of children affected by Wilms tumor. Clinical trials have been responsible for many of the advances that have transformed Wilms tumor from a frequently fatal disease into one of the most successfully treated childhood cancers.

 

Wilms Tumor Evidence Base

The Wilms Tumor Evidence Base refers to the collective body of scientific knowledge generated through clinical trials, research studies, systematic reviews, treatment protocols, and international collaborations. This evidence base guides modern medical practice and continues to shape future advances in childhood kidney cancer care.